RE:RE:Holding longGood post. Thomas needs to clarify in an easy to understand and transparent manner the status of the data from Aspire as well as the effect the lawsuit has on corporate impairment. Investors are selling for 2 reasons: constant delays in clinical results and a general lack of transparency. I would like to think its a communication issue but obviously investors are speaking loudly through the heavy selling at significant losses. As for me, i'm holding. At current levels, i'll ride the risk reward and see how it goes. I'll take a year end loss if the company fails to deliver.